Skip to content

The Effectiveness of Acceptance and Commitment Therapy (ACT) in patients presenting with Depression in Saudi Arabia

Adel Aldaha

University Of Wales Trinity Saint David Research Repository October 28, 2026 DOI: 10.82227/repository.uwtsd.ac.uk.00004389 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review and meta-analysis plus randomized controlled trial Peer reviewed
Sample size 34
Population Adults diagnosed with depression at King Khalid University Hospital, Saudi Arabia (17 ACT, 17 standard care)
Intervention Acceptance and Commitment Therapy (ACT)
Duration Measured pre-intervention, post-intervention, and follow-up
Measures BDI, PHQ-9, GAD-7, TMAS, KIMS, MAAS, ATQ-F, ATQ-B, WBSI
Topics Depression
Key findings The meta-analysis indicates ACT produces moderate, statistically significant reductions in depressive symptoms across populations and delivery models. In the Saudi trial, ACT participants' BDI scores fell from 36.06 to 18.88 and PHQ-9 from 17.71 to 8.65, with negligible change in controls, alongside improvements in anxiety, negative thoughts, and mindfulness; group assignment was the strongest moderator, and the authors suggest booster sessions to sustain gains.

Abstract

Background: Depression continues to be a serious public mental health issue in Saudi Arabia. Cultural stigma, fewer resources, and reliance on medication limits access to evidence-based psychotherapies. Acceptance and Commitment Therapy (ACT) is a third-wave cognitive-behavioural intervention that promotes the use of mindfulness, psychological flexibility, and values-based living, which has potential for cultural adaptation. This thesis evaluated the efficacy of ACT through a systematic review and meta-analysis of the international literature, and an empirical clinical trial in Saudi Arabia.

Methods: A systematic review and meta-analysis was undertaken in accordance with PRISMA; a comprehensive review of published randomised controlled trials (RCTs) of ACT for depression published from 2019 to 2024 was completed. The researcher also conducted a quantitative experimental study at King Khalid University Hospital. Thirty-four participants diagnosed with depression were randomised into either the ACT intervention group (n=17), or standard care control group (n=17). Psychological indicators of depression (BDI, PHQ-9), anxiety (GAD-7, TMAS), mindfulness (KIMS, MAAS), cognitive fusion (ATQ-F, ATQ-B), and thought suppression (WBSI) were measured three times: pre-intervention (T1), post-intervention (T2), and follow-up (T3). The data were analysed using repeated measure ANOVA, independent t-tests and regression models using SPSS v30.

Results: The meta-analysis found ACT produced moderate levels of statistically significant reductions in depressive symptoms across various populations and delivery models. Additionally, the Saudi clinical trial demonstrated improvements in depression scores for ACT participants, specifically, BDI interventions decreased from 36.06 to 18.88, and PHQ-9 dropped from 17.71 to 8.65, contrasting with negligible change in controls. Improvements were seen in anxiety scores (GAD-7, TMAS) and negative thoughts (ATQ, WBSI), while mindfulness (KIMS, MAAS) was meaningfully better. Time × Group interactions were large and statistically significant, thus supporting ACT intervention versus standard care. Regression analyses showed group assignment was the strongest moderator of outcomes, while gender and age were of lesser importance. Improvements were deemed most beneficial immediately post-treatment and at follow-up, but regression to the mean was suspected on delayed assessments; thus, future booster sessions would be beneficial.

Conclusion: This thesis provides converging findings from international trials, with a Saudi-based experiment that ACT represents an effective intervention that adapts for cultural resonance and acceptance for depression and related distress. ACT improves aspects of mindfulness, cognitive rigidity, and results in sustainable improvements to respondents' mental health. In Saudi Arabia, ACT therapy could be embedded into healthcare service provision through digital and scalable models to close treatment access barriers, reduce stigma, and offer a credible one-step improvement pathway. Long-term maintenance boosters are considered to convert the therapeutic gains to longer-term benefits.

Comparable studies

Other systematic reviews and meta-analyses on depression, most cited first.

Study Year Design Participants
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression Participants with major depression in placebo-controlled, double-blind, randomized... 2015 Systematic review and meta-analysis
Side-effects associated with ketamine use in depression: a systematic review. Patients with depression 2018 Systematic review
Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis Adults with unipolar or bipolar major depression 2020 Systematic review and meta-analysis n = 1,877
Single-dose infusion ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories Patients with major depressive disorder or bipolar depression 2016 Systematic review and meta-analysis n = 588
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies Patients with cancer- or illness-related anxiety and depression, major depressive... 2020 Systematic review n = 188

Explore topics